These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 8274579
1. Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics. Duncan E, Wolkin A, Angrist B, Sanfilipo M, Wieland S, Cooper TB, Rotrosen J. Biol Psychiatry; 1993 Oct 15; 34(8):523-8. PubMed ID: 8274579 [Abstract] [Full Text] [Related]
2. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations. Davidson M, Kahn RS, Knott P, Kaminsky R, Cooper M, DuMont K, Apter S, Davis KL. Arch Gen Psychiatry; 1991 Oct 15; 48(10):910-3. PubMed ID: 1929760 [Abstract] [Full Text] [Related]
6. Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis. Mazure CM, Nelson JC, Jatlow PI, Bowers MB. Biol Psychiatry; 1991 Sep 01; 30(5):475-82. PubMed ID: 1932395 [Abstract] [Full Text] [Related]
7. The acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patients. Konicki PE, Owen RR, Litman RE, Pickar D. Life Sci; 1991 Sep 01; 48(14):1411-6. PubMed ID: 2008157 [Abstract] [Full Text] [Related]
9. Evolution of plasma homovanillic acid (HVA) in chronic schizophrenic patients treated with haloperidol. Galinowski A, Poirier MF, Aymard N, Leyris A, Beauverie P, Bourdel MC, Loo H. Acta Psychiatr Scand; 1998 Jun 01; 97(6):458-66. PubMed ID: 9669519 [Abstract] [Full Text] [Related]
10. Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations. Suzuki E, Kanba S, Koshikawa H, Nibuya M, Yagi G, Asai M. J Psychiatry Neurosci; 1996 May 01; 21(3):167-71. PubMed ID: 8935328 [Abstract] [Full Text] [Related]
15. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment. Kahn RS, Davidson M, Knott P, Stern RG, Apter S, Davis KL. Arch Gen Psychiatry; 1993 Aug 01; 50(8):599-605. PubMed ID: 7688208 [Abstract] [Full Text] [Related]
16. Effects of single dose haloperidol administration on plasma homovanillic acid levels in normal subjects. Magliozzi JR, Doran AR, Gietzen DW, Olson AM, Maclin EL, Tuason VB. Psychiatry Res; 1993 May 01; 47(2):141-9. PubMed ID: 8341767 [Abstract] [Full Text] [Related]
17. Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients. Chang WH, Lin SK, Jann MW, Lam YW, Chen TY, Chen CT, Hu WH, Yeh EK. Biol Psychiatry; 1989 Jul 01; 26(3):239-49. PubMed ID: 2742942 [Abstract] [Full Text] [Related]
18. Differential effects of haloperidol on negative symptoms in drug-naive schizophrenic patients: effects on plasma homovanillic acid. Labarca R, Silva H, Jerez S, Ruiz A, Forray MI, Gysling K, Andres ME, Bustos G, Castillo Y, Hono J. Schizophr Res; 1993 Mar 01; 9(1):29-34. PubMed ID: 8461269 [Abstract] [Full Text] [Related]
19. Studies on concentrations of NA and HVA and activity of DBH in the serum from schizophrenic patients, first-degree relatives and normal subjects. Wei J, Ramchand CN, Hemmings GP. Schizophr Res; 1992 Dec 01; 8(2):103-10. PubMed ID: 1360811 [Abstract] [Full Text] [Related]
20. Plasma homovanillic acid and treatment response in a large group of schizophrenic patients. Chang WH, Hwu HG, Chen TY, Lin SK, Lung FW, Chen H, Lin WL, Hu WH, Lin HN, Chien CP. Schizophr Res; 1993 Oct 01; 10(3):259-65. PubMed ID: 8260444 [Abstract] [Full Text] [Related] Page: [Next] [New Search]